rs4646179
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001371415.1(ACE2):āc.2070T>Cā(p.Asn690=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00377 in 1,209,518 control chromosomes in the GnomAD database, including 101 homozygotes. There are 1,221 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.018 ( 45 hom., 527 hem., cov: 23)
Exomes š: 0.0023 ( 56 hom. 694 hem. )
Consequence
ACE2
NM_001371415.1 synonymous
NM_001371415.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0640
Genes affected
ACE2 (HGNC:13557): (angiotensin converting enzyme 2) The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. ACE2 is known to be expressed in various human organs, and its organ- and cell-specific expression suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2, the latter is the causative agent of coronavirus disease-2019 (COVID-19). Multiple splice variants have been found for this gene and the dACE2 (or MIRb-ACE2) splice variant has been found to be interferon inducible. [provided by RefSeq, Nov 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant X-15566297-A-G is Benign according to our data. Variant chrX-15566297-A-G is described in ClinVar as [Benign]. Clinvar id is 778980.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.064 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0592 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACE2 | NM_001371415.1 | c.2070T>C | p.Asn690= | synonymous_variant | 16/18 | ENST00000252519.8 | NP_001358344.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACE2 | ENST00000252519.8 | c.2070T>C | p.Asn690= | synonymous_variant | 16/18 | 1 | NM_001371415.1 | ENSP00000252519 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0181 AC: 2026AN: 111676Hom.: 45 Cov.: 23 AF XY: 0.0155 AC XY: 526AN XY: 33866
GnomAD3 genomes
AF:
AC:
2026
AN:
111676
Hom.:
Cov.:
23
AF XY:
AC XY:
526
AN XY:
33866
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00561 AC: 1026AN: 182741Hom.: 23 AF XY: 0.00355 AC XY: 239AN XY: 67285
GnomAD3 exomes
AF:
AC:
1026
AN:
182741
Hom.:
AF XY:
AC XY:
239
AN XY:
67285
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00231 AC: 2535AN: 1097790Hom.: 56 Cov.: 29 AF XY: 0.00191 AC XY: 694AN XY: 363200
GnomAD4 exome
AF:
AC:
2535
AN:
1097790
Hom.:
Cov.:
29
AF XY:
AC XY:
694
AN XY:
363200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0181 AC: 2026AN: 111728Hom.: 45 Cov.: 23 AF XY: 0.0155 AC XY: 527AN XY: 33928
GnomAD4 genome
AF:
AC:
2026
AN:
111728
Hom.:
Cov.:
23
AF XY:
AC XY:
527
AN XY:
33928
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 30, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at